
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Description
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Summary
GlobalData's Medical Devices sector report, “Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Bacteriology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Bacteriology comprises of Reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to -
Summary
GlobalData's Medical Devices sector report, “Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Bacteriology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Bacteriology comprises of Reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Bacteriology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bacteriology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Bacteriology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
421 Pages
- About GlobalData
- Bacteriology - Pipeline Products by Stage of Development
- Bacteriology Overview
- Bacteriology - Pipeline Products by Segment
- Bacteriology - Pipeline Products by Territory
- Bacteriology - Pipeline Products by Regulatory Path
- Bacteriology - Pipeline Products by Estimated Approval Date
- Bacteriology - Ongoing Clinical Trials
- Bacteriology Companies - Pipeline Products by Stage of Development
- Bacteriology - Companies Pipeline Products by Stage of Development
- 3a-Diagnostics GmbH Company Overview
- Abacus Diagnostica Ltd Company Overview
- Adaltis Srl Company Overview
- Advanced Laboratory Services, INC. Company Overview
- Akonni Biosystems Inc Company Overview
- Alere Inc Company Overview
- American Bio Medica Corp Company Overview
- Amity University Company Overview
- Angle Biosciences Inc Company Overview
- Antigen Discovery Inc Company Overview
- Applied BioCode Inc Company Overview
- Ares Genetics GmbH Company Overview
- Aseptika Ltd Company Overview
- Astute Medical Inc Company Overview
- Asylia Diagnostics BV Company Overview
- Ayanda Biosystems SA (Inactive) Company Overview
- Beckman Coulter Inc Company Overview
- Biocartis Group NV Company Overview
- Biocrates Life Sciences AG Company Overview
- BioFilm Control SAS Company Overview
- BioHelix Corp Company Overview
- Biointerfaces Institute Company Overview
- Biois Corp Company Overview
- BioMaxima SA Company Overview
- bioMerieux SA Company Overview
- Biopeptide corp Company Overview
- BioSentinel Pharmaceuticals, Inc. Company Overview
- Biotechnology Assets SA Company Overview
- Bordeaux University Hospital Company Overview
- Brigham Young University Inc Company Overview
- C3J Therapeutics Inc (Inactive) Company Overview
- Calypte Biomedical Corporation Company Overview
- Carolina Liquid Chemistries Corp Company Overview
- CellCarta Biosciences Inc Company Overview
- Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview
- Cepheid Inc Company Overview
- Children's Hospital of Michigan Company Overview
- China Medical Technologies Inc (Inactive) Company Overview
- Co-Diagnostics Inc Company Overview
- Conrad Company Overview
- Coris BioConcept Company Overview
- Courtagen Life Sciences Inc Company Overview
- Cubed Laboratories LLC Company Overview
- Cupid Ltd Company Overview
- Daan Gene Co Ltd Company Overview
- Defence Science and Technology Laboratory Company Overview
- DIANA Biotechnologies SRO Company Overview
- DiaSorin SpA Company Overview
- DSX Therapeutics LLC Company Overview
- Ellume Ltd Company Overview
- Emory University Company Overview
- Enigma Diagnostics Ltd (Inactive) Company Overview
- EUROIMMUN US LLC Company Overview
- First Light Diagnostics Inc Company Overview
- FK-Biotecnologia SA Company Overview
- Focus Diagnostics Inc Company Overview
- Foundation for Innovative New Diagnostics Company Overview
- Fyodor Biotechnologies, Inc. Company Overview
- Genekam Biotechnology AG Company Overview
- Genome Diagnostics Pvt Ltd Company Overview
- GNA Biosolutions GmbH Company Overview
- Godx Inc Company Overview
- Great Basin Scientific Inc. Company Overview
- Guanine Inc Company Overview
- HAV Vaccines Ltd Company Overview
- HDT Biotech Corp Company Overview
- Health and Bliss (Inactive) Company Overview
- Helixbind Inc Company Overview
- Helmholtz Centre for Infection Research Company Overview
- HiberGene Diagnostics Ltd Company Overview
- Hutman Diagnostics AG Company Overview
- iCubate Inc Company Overview
- InBios International Inc Company Overview
- Innovative Biosensors, Inc. Company Overview
- InstantLabs Inc Company Overview
- Institute for Development Research Company Overview
- Jagiellonian University Company Overview
- Johns Hopkins University Company Overview
- Kaneka Corp Company Overview
- L2 Diagnostics LLC Company Overview
- Luminex Corp Company Overview
- Marx Biotechnology Ltd Company Overview
- Master Diagnostica Sociedad Limitada Company Overview
- Medica Corp Company Overview
- Meridian Bioscience Inc Company Overview
- MicroPhage Inc (Inactive) Company Overview
- Molecular Detection Inc (Inactive) Company Overview
- MyCartis NV Company Overview
- Mylab Discovery Solutions Pvt Ltd Company Overview
- Nanosphere Inc (Inactive) Company Overview
- National Cheng-Kung University Hospital Company Overview
- Naval Medical Research Center Company Overview
- NeuMoDx Molecular Inc Company Overview
- Newcastle University Company Overview
- North Carolina State University Company Overview
- Novartis AG Company Overview
- OpGen Inc Company Overview
- Optolane Technologies Inc Company Overview
- Pathogenica Inc Company Overview
- Pennsylvania State University Company Overview
- Pictor Ltd Company Overview
- PositiveID Corp Company Overview
- Presymptom Health Ltd Company Overview
- Proactive Oral Solutions, Inc. Company Overview
- ProCelo AS Company Overview
- Promyco Diagnostics Ltd (Inactive) Company Overview
- Qiagen NV Company Overview
- Quidel Corp Company Overview
- RedHill Biopharma Ltd Company Overview
- Renishaw Plc Company Overview
- Rheonix Inc Company Overview
- Roche Diagnostics International Ltd Company Overview
- Rockefeller University Company Overview
- Sansure Biotech Inc Company Overview
- Seegene Inc Company Overview
- Sex Positive Diagnostics Company Overview
- Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
- Shenzhen New Industries Biomedical Engineering Co Ltd Company Overview
- SomaLogic Inc Company Overview
- Spanish National Research Council Company Overview
- SpeeDx Pty Ltd Company Overview
- TBG Diagnostics Ltd Company Overview
- The University of Nottingham Company Overview
- Tosoh Bioscience Inc Company Overview
- Transfusion & Transplantation Technologies (Inactive) Company Overview
- Trillium Diagnostics LLC (Inactive) Company Overview
- University at Buffalo Company Overview
- University of Calgary Company Overview
- University of California San Diego Company Overview
- University of California San Francisco Company Overview
- University of Cincinnati Company Overview
- University of Leicester Company Overview
- University of Liverpool Company Overview
- University of Maryland Baltimore Company Overview
- University of Melbourne Company Overview
- University of Michigan Company Overview
- University of Oxford Company Overview
- University of Pennsylvania Company Overview
- University of Strathclyde Company Overview
- University of Washington Company Overview
- University of Wisconsin Madison Company Overview
- Verax Biomedical Inc Company Overview
- Victory Square Health Inc Company Overview
- Yale University Company Overview
- Nov 14, 2022: Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
- Nov 03, 2022: Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
- Nov 01, 2022: Genetic Analysis Announces Interim report January - September 2022
- Nov 01, 2022: Co-Diagnostics Appoints Dr. Mark Poritz as New Chief Scientific Officer
- Nov 01, 2022: Genetic Analysis : Interim report January - September 2022
- Oct 27, 2022: OpGen Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2022 and Provides Business Update
- Oct 27, 2022: Meridian of Michigan appoints Patricia Graham as CEO
- Oct 27, 2022: Co-Diagnostics Announces Third Quarter 2022 Earnings Release Date and Webcast
- Oct 27, 2022: Bio-Rad Reports Third-Quarter 2022 Financial Results
- Oct 21, 2022: Biocartis Reports Results of Third Quarter of 2022
- Oct 19, 2022: Renishaw full-year results reports record revenue increase
- Oct 17, 2022: Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
- Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
- Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring
- Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
- Oct 11, 2022: Omega Diagnostics Group Scientific Director to present at FIDHC
- Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
- Sep 30, 2022: Renishaw Annual Report 2022
- Sep 27, 2022: Neogen Announces First Quarter Results
- Sep 27, 2022: Omega Diagnostics Group PLC Posting of Annual Report and confirmation of AGM
- Sep 16, 2022: Renishaw Preliminary announcement of results for the year ended 30 June 2022
- Sep 12, 2022: Co-Diagnostics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
- Sep 12, 2022: Neogen Announces the Appointment of Two New Board Members
- Sep 08, 2022: Cardinal Health Announces Pharmaceutical Segment Organizational Changes
- Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference
- Sep 06, 2022: Labcorp to Speak at the Baird 2022 Global Healthcare Conference
- Sep 05, 2022: Renishaw Register for the 2022 full-year results webcast
- Sep 01, 2022: Bayer Announces Appointment of Kimberly Mathisen to Supervisory Board
- Sep 01, 2022: Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
- Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer
- Aug 25, 2022: Biocartis Announces 2022 Half-Year Results on 1 September 2022
- Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference
- Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement
- Aug 23, 2022: Novartis set to eliminate many leadership positions as part of 1,400 layoffs in Switzerland
- Aug 22, 2022: Co-Diagnostics to Present at 14th Next Generation Dx Summit in Washington, D.C.
- Aug 18, 2022: QIAGEN issues 2021 Sustainability Report
- Aug 15, 2022: MyMD Pharmaceuticals announce quarter ended June 30, 2022
- Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022
- Aug 11, 2022: Co-Diagnostics Reports Second Quarter 2022 Financial Results
- Aug 10, 2022: Biohit announce Half Year Financial Report 2022.
- Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer
- Jul 28, 2022: Labcorp Announces 2022 Second Quarter Results
- Jul 28, 2022: Bio-rad Reports Second-quarter 2022 Financial Results
- Jul 26, 2022: QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
- Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
- Jul 24, 2022: Central Trust Buys 136 Shares of Novartis AG
- Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
- Jul 18, 2022: Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
- Jul 14, 2022: MedMira Strengthens and Expands Board
- Jul 08, 2022: Opgen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022
- Jul 07, 2022: Neogen Announces Pricing of $350.0 Million Senior Notes Offering and Entry into $800.0 Million Senior Secured Credit Agreement by Garden SpinCo
- Jul 07, 2022: Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11
- Jul 05, 2022: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022
- Jul 01, 2022: Novartis Leaning Toward Spinoff of $25 Billion Generics Arm
- Jun 28, 2022: Novartis to cut up to 8,000 jobs globally
- Jun 24, 2022: Quotient Ltd Provides Fourth Quarter Fiscal 2022 Results and Business Update
- Jun 24, 2022: Quotient Provides Fourth Quarter Fiscal 2022 Results and Business Update
- Jun 21, 2022: Quotient Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
- Jun 17, 2022: Quotient to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd
- Jun 15, 2022: Co-Diagnostics to Present at Sidoti Summer Small Cap Virtual Conference
- Jun 09, 2022: EKF Diagnostics Holdings : Launch of EKF Link
- Jun 08, 2022: PixCell Medical Names Mark Erez as Chief Financial Officer
- Jun 07, 2022: BD Names Simon Campion as Medical Segment President
- Jun 07, 2022: Daan Gene Announcement on the Resignation of the General Manager of the Company
- Jun 02, 2022: BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
- Jun 02, 2022: Eisai to Present Latest Data on Lemborexant at the 36th Annual Sleep 2022 Meeting
- May 26, 2022: Quest Diagnostics to Speak at the Jefferies Healthcare Conference
- May 24, 2022: Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
- May 23, 2022: Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022
- May 19, 2022: Co-Diagnostics to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26
- May 19, 2022: U of I trustees appoint new chancellor at UIS
- May 18, 2022: Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America
- May 17, 2022: Labcorp to Speak at the UBS 2022 Global Healthcare Conference
- May 16, 2022: Accelerate Diagnostics Reports First Quarter 2022 Financial Results
- May 13, 2022: Seegene reports first quarter 2022 financial results
- May 11, 2022: Quest Diagnostics to Speak at the UBS 2022 Global Healthcare Conference
- May 10, 2022: Bayer Group Announced First quarter 2022 strong sales and earnings growth
- May 10, 2022: Eppendorf increases 2021 revenue to 1.1 billion
- May 05, 2022: Cardinal Health Reports Third Quarter Fiscal 2022 Results
- May 04, 2022: Luminex announces upcoming initial public offering
- May 04, 2022: Labcorp to Webcast Its Annual Meeting of Shareholders
- May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results
- Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference
- Apr 28, 2022: T2 Biosystems Announces Formation and Members of Scientific Advisory Board
- Apr 28, 2022: Co-Diagnostics Announces First Quarter 2022 Earnings Release Date and Webcast
- Apr 26, 2022: Quotient Announces Appointment of New Board Member
- Apr 25, 2022: PixCell Medical Appoints Ryan Venturi as General Manager of Newly Opened US Office
- Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM
- Apr 21, 2022: Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%
- Apr 21, 2022: Bayer appoints Tara Frenkl as the new Head of Oncology Development at its Oncology Strategic Business Unit
- Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
- Apr 14, 2022: Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
- Apr 14, 2022: nRichDX and Eppendorf to jointly present at ESHG 2022 Meeting
- Apr 12, 2022: Queen's University to host Belfast/Good Friday Agreement 25th Anniversary Conference
- Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day
- Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022
- Apr 06, 2022: OpGen's subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
- Apr 04, 2022: Novartis appoints Shreeram Aradhye as chief medical officer
- Mar 31, 2022: Renishaw announces Directorate Change
- Mar 29, 2022: Accelerate Diagnostics launches Arc system for use in blood culture test
- Mar 29, 2022: T2 Biosystems to Host Analyst and Investor Day on April 12, 2022
- Mar 29, 2022: Genedrive Announces Interim results to 31 December 2021
- Mar 24, 2022: Neogen Announces Third Quarter Results
- Mar 17, 2022: Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
- Mar 17, 2022: Co-Diagnostics Makes Strategic Additions to Scientific Advisory Board
- Mar 17, 2022: Genedrive Appoints Russell John Shaw as Chief Financial Officer
- Mar 15, 2022: OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year
- Mar 14, 2022: Co-diagnostics Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Webcast
- Mar 14, 2022: Qiagen Announces 20-f Annual Report Filing for 2021 Results
- Mar 08, 2022: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results
- Mar 04, 2022: Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
- Mar 03, 2022: binx health Announces Appointment of UnitedHealth Group's Optum Rx Chief Financial Officer Jeff Grosklags to its Board of Directors
- Mar 02, 2022: Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
- Mar 01, 2022: Cardiff Oncology to Participate in Cowen's 42nd Annual Healthcare Conference
- Feb 24, 2022: Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results
- Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference
- Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD
- Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer
- Feb 17, 2022: Biocartis Group announces 2021 full year results on 24 february 2022
- Feb 17, 2022: Seegene Announces Q4 and Full-Year 2021 Financial Results
- Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
- Feb 14, 2022: Bio-Rad Laboratories to Post Q1 2022 Earnings of $2.80 Per Share, Jefferies Financial Group Forecasts
- Feb 10, 2022: Sysmex announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022
- Feb 08, 2022: Quotient Reports Third Quarter Fiscal 2022 Results and Provides Business Update
- Feb 03, 2022: Cardinal Health Reports Second Quarter Fiscal 2022 Results
- Feb 03, 2022: Renishaw Announces half-year results for the six months to 31 December 2021
- Feb 02, 2022: Novartis Announces 2021 Financial Results
- Feb 02, 2022: Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time
- Feb 02, 2022: Bio-Rad to Host Investor Day on February 25
- Jan 31, 2022: EKF Diagnostics Holdings Announces Non-executive Directorate Change
- Jan 31, 2022: MedMira Reports Second Quarter Results FY2022
- Jan 26, 2022: New settle plate stands for environmental monitoring of pharmaceutical cleanrooms
- Jan 24, 2022: Eisai announces the appointment of tricia brooks as vice president & head of office, government affairs and policy
- Jan 19, 2022: Omega Diagnostics Group Announces Directorate Change
- Jan 13, 2022: Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
- Jan 13, 2022: Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
- Jan 11, 2022: Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs
- Jan 11, 2022: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
- Jan 10, 2022: Co-Diagnostics to Participate in the HC Wainwright 2022 BioConnect Virtual Conference on January 10-13
- Jan 07, 2022: Quidel Announces Preliminary Revenue for Fourth Quarter 2021
- Jan 06, 2022: BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
- Jan 04, 2022: Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
- Jan 03, 2022: Ortho Clinical Diagnostics to Participate in the 40th Annual JP Morgan Healthcare Conference
- Jan 03, 2022: Renishaw announces Directorate Change
- Jan 02, 2022: Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
- Dec 29, 2021: Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022
- Dec 29, 2021: BioMe and Yonsei Medical Center sign technology transfer contract for pathbreaking microbiome treatment
- Dec 28, 2021: CDC awards $2 million to penn to combat antimicrobial resistance in Southern Africa
- Dec 21, 2021: Neogen Announces Second Quarter Results 2022
- Dec 21, 2021: BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business
- Dec 20, 2021: Renishaw Announces Directorate Change
- Dec 17, 2021: MedMira appoints Thomas Bergmann to board
- Dec 16, 2021: Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
- Dec 15, 2021: Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company's Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
- Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
- Nov 30, 2021: MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.